Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by FREDRICK B HAGEMEISTER and RICHARD ERIC DAVIS.
FREDRICK B HAGEMEISTER
Connection Strength
0.031
RICHARD ERIC DAVIS
  1. Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial. Lancet Oncol. 2014 Nov; 15(12):1311-8.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.